Stocksigma LogoStocksigma Logo

iSERA Lifesciences Reports Q2 FY27 Results with Continued Net Losses

iSERA Lifesciences Limited reported nil revenue from operations for the quarter ended 30th Sep'26, matching Q1 FY27 and Q2 FY26

iSERA Lifesciences Reports Q2 FY27 Results with Continued Net Losses

iSERA Lifesciences Ltd · Financial Result · 04 Nov 2026, 11:13 pm

iSERA Lifesciences Reports Q2 FY27 Results with Continued Net Losses iSERA Lifesciences Limited reported nil revenue from operations for the quarter ended 30th Sep'26, matching Q1 FY27 and Q2 FY26. Total income stood at ₹7.88 lakh, derived entirely from other income. Total expenses reached ₹20.99 lakh compared to ₹33.62 lakh in Q1 FY27 and ₹0.30 lakh in Q2 FY26. The company posted a net loss of ₹13.11 lakh versus a loss of ₹33.62 lakh in Q1 FY27 and a profit of ₹0.70 lakh in Q2 FY26. Quarterly basic and diluted EPS was negative ₹0.62.

Original exchange filing (PDF)

More announcements from iSERA Lifesciences Ltd

All iSERA Lifesciences Ltd announcements